002393 Stock Overview
Engages in the research and development, production, and sale of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Tianjin Lisheng Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.96 |
| 52 Week High | CN¥19.44 |
| 52 Week Low | CN¥12.61 |
| Beta | 0.21 |
| 1 Month Change | -4.40% |
| 3 Month Change | -3.47% |
| 1 Year Change | 0.87% |
| 3 Year Change | 19.62% |
| 5 Year Change | -11.86% |
| Change since IPO | -59.27% |
Recent News & Updates
Take Care Before Diving Into The Deep End On Tianjin Lisheng Pharmaceutical Co.,Ltd. (SZSE:002393)
Jan 10
These 4 Measures Indicate That Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Is Using Debt Safely
Sep 28Recent updates
Take Care Before Diving Into The Deep End On Tianjin Lisheng Pharmaceutical Co.,Ltd. (SZSE:002393)
Jan 10These 4 Measures Indicate That Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Is Using Debt Safely
Sep 28Tianjin Lisheng PharmaceuticalLtd (SZSE:002393) Strong Profits May Be Masking Some Underlying Issues
Mar 28Shareholder Returns
| 002393 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.5% | 0.4% | 0.6% |
| 1Y | 0.9% | 0.2% | 12.8% |
Return vs Industry: 002393 matched the CN Pharmaceuticals industry which returned 0.2% over the past year.
Return vs Market: 002393 underperformed the CN Market which returned 12.8% over the past year.
Price Volatility
| 002393 volatility | |
|---|---|
| 002393 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in CN Market | 10.9% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 002393 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002393's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 1,328 | Fujun Wang | www.lishengpharma.com |
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers its products in various forms comprising tablets, soft capsules, granules, flat films, pills, mixture, and injection for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, sensory system, systemic anti-infection, respiratory system, endocrine system, digestive system, and cardiovascular system, as well as drugs for invigorating qi and blood.
Tianjin Lisheng Pharmaceutical Co.,Ltd. Fundamentals Summary
| 002393 fundamental statistics | |
|---|---|
| Market cap | CN¥4.34b |
| Earnings (TTM) | CN¥188.41m |
| Revenue (TTM) | CN¥1.27b |
23.0x
P/E Ratio3.4x
P/S RatioIs 002393 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002393 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.27b |
| Cost of Revenue | CN¥593.72m |
| Gross Profit | CN¥671.52m |
| Other Expenses | CN¥483.10m |
| Earnings | CN¥188.41m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 21, 2025
| Earnings per share (EPS) | 0.74 |
| Gross Margin | 53.07% |
| Net Profit Margin | 14.89% |
| Debt/Equity Ratio | 1.6% |
How did 002393 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield58%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/23 22:08 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin Lisheng Pharmaceutical Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peng Yan | Changjiang Securities Co. LTD. |
| Jie Yao | Everbright Securities Co. Ltd. |
| Ting Huang | Sinolink Securities Co., Ltd. |